Many advocacy groups have been pushing for the use of cannabis to combat the country’s massive opioid crisis but a solid foundation on its efficiency is hard to come by. That is until a current study reveals how a one-two punch approach may just be the hope we’ve been looking for.
Backed by research
Per a study titled “Implications of prescription drug monitoring and medical cannabis legislation on opioid overdose mortality” published by the National Center for Biotechnology Information, an adequate combination of cannabis and prescription drug monitoring would be essential to decrease opioid-related deaths.
The study successfully showed that opioid-related mortality is slower in states with existing marijuana laws than those with only prescription drug monitoring programs. This is supported by another research conducted in 2014 and published by the Journal of the American Medical Association which found that states with medical cannabis laws had a 24.8 percent lower mean annual opioid overdose mortality rate compared with states without medical cannabis laws.
Iowa-based physician Dr. Joe Goldstrich became an advocate for cannabis as opioid replacement after he witnessed its benefits first-hand. Back in 2014 in a California clinic, he had a chance to observe patients reduce opioids to safer levels after cannabis therapy.
As part of the Arkansas medical team that’s working on crafting medical guidelines for cannabis, he hopes to educate more physicians by offering classes this summer to teach about the potentials of the drug, the science behind it, and how various strains can be used to treat an array of many deadly symptoms and ailments.